Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/48165
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Malakoutikhah, Morteza | - |
dc.contributor.author | Gómara Elena, María José | - |
dc.contributor.author | Gómez-Puerta, José A. | - |
dc.contributor.author | Sanmartí, Raimon | - |
dc.contributor.author | Haro Villar, Isabel | - |
dc.date.accessioned | 2012-04-12T09:41:32Z | - |
dc.date.available | 2012-04-12T09:41:32Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Journal of Medicinal Chemistry | es_ES |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | http://hdl.handle.net/10261/48165 | - |
dc.description.abstract | Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation and, in many cases, destruction of the joints. To prevent progressive and irreversible structural damage, early diagnosis of RA is of paramount importance. The present study addresses the search of new RA citrullinated antigens that could supplement or complement diagnostic/prognostic existing tests. With this aim, the epitope anticitrullinated vimentin antibody response was mapped using synthetic peptides. To improve the sensitivity/specificity balance, a vimentin peptide that was selected, and its cyclic analogue, were combined with fibrin- and filaggrin-related peptides to render chimeric peptides. Our findings highlight the putative application of these chimeric peptides for the design of RA diagnosis systems and imply that more than one serological test is required to classify RA patients based on the presence or absence of ACPAs. Each of the target molecules reported here (fibrin, vimentin, filaggrin) has a specific utility in the identification of a particular subset of RA patients. | es_ES |
dc.description.sponsorship | This work has been partially funded by Grant FIS PI080207 from the Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain. | - |
dc.language.iso | eng | es_ES |
dc.publisher | American Chemical Society | es_ES |
dc.rights | closedAccess | es_ES |
dc.title | The Use of Chimeric Vimentin Citrullinated Peptides for the Diagnosis of Rheumatoid Arthritis | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.1021/jm200563u | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1021/jm200563u | es_ES |
dc.identifier.e-issn | 1520-4804 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | artículo | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (IQAC) Artículos |
CORE Recommender
SCOPUSTM
Citations
19
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
19
checked on 26-feb-2024
Page view(s)
339
checked on 26-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.